Cross-Sector entity
FDA is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. e-commerce accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Retail Pharmacies appears in 2 tracked Cross-Sector stories published from March 20, 2026 through March 23, 2026.
2 verified stories tracked
Last mentioned: Mar 23, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
FDA is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. e-commerce accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Retail Pharmacies appears in 2 tracked Cross-Sector stories published from March 20, 2026 through March 23, 2026. Each carries 11.5 original sources on average.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Retail Pharmacies. Shared-story counts are live from our verified record — not editorial picks.
Retail Removal
Pharmacies and major retailers initiate the physical removal of affected lot numbers from inventory.
FDA Confirmation
The FDA confirms the recall of 90,000 bottles and provides guidance for consumers and retailers.
Initial Recall Reports
News of a large-scale pediatric ibuprofen recall begins to circulate nationwide.
A nationwide recall has been issued for alcohol pads due to life-threatening bacterial contamination, forcing major retailers and e-commerce platforms to halt sales immediately. The recall highlights critical vulnerabilities in the medical supply chain and the challenges of managing reverse logistics for contaminated antiseptic products.
The FDA has initiated a nationwide recall of approximately 90,000 bottles of children's ibuprofen, citing significant safety concerns. This large-scale action highlights the critical importance of pediatric dosage accuracy and the role of digital supply chain tracking in modern healthcare.
Source: wbir.com · fox13news.com
